Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer

(1) Background: There are currently limited treatments for castration-resistant prostate cancer. Immunotherapy involving Sipuleucel-T has increasingly drawn attention for prostate cancer management. BCG plays a vital role in treating bladder cancer, mainly by inducing immune activation, but is rarel...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Linpei Guo, Hui Xie, Zheng Zhang, Zhun Wang, Shuanghe Peng, Yuanjie Niu, Zhiqun Shang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2021-07-01
Edice:	Vaccines
Témata:	Ag85B <i>Mycobacterium</i> <i>tuberculosis</i> STEAP1 six-transmembrane epithelial antigen of the prostate 1 immune response prostate cancer
On-line přístup:	https://www.mdpi.com/2076-393X/9/7/786
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!